The UAB Center for Pediatric-Onset Demyelinating Disease (CPODD) is one of the founding Pediatric Multiple Sclerosis (MS) Centers of Excellence in the country designated and funded in 2006 by the ...

The neurologist explains the link between Guillain-Barre Syndrome and paralysis, and the initial symptoms to watch out for.

Chronic inflammatory demyelinating polyneuropathy (CIDP ... Vyvgart Hytrulo works by reducing the level of pathogenic (disease-causing) immunoglobulin G (IgG) antibodies in your bloodstream.

Chronic inflammatory demyelinating polyneuropathy (CIDP ... in CIDP because of the rarity and heterogeneity of the disease," ...

Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively disabling disease of unknown cause. The first pathological descriptions of the disease ...

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...